Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors (Q39904164)

15 September 2017

title

Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors (English)

1 reference

15 September 2017

7

1 reference

15 September 2017

8

1 reference

15 September 2017

9

1 reference

15 September 2017

Stefan Schäfer

1

1 reference

15 September 2017

Laura Saunders

2

1 reference

15 September 2017

Sonja Schlimme

3

1 reference

15 September 2017

Vassil Valkov

4

1 reference

15 September 2017

Julia M Wagner

5

1 reference

15 September 2017

Felix Kratz

6

1 reference

15 September 2017

publication date

1 February 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

283-290

1 reference

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Chromatin modifications as targets for new anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Histone Deacetylase Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

The human histone deacetylase family

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

HDAC6 is a microtubule-associated deacetylase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Histone deacetylase inhibitors: from bench to clinic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Subtype selective substrates for histone deacetylases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Crystal structure of a bacterial class 2 histone deacetylase homologue

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Structural origin of selectivity in class II-selective histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Design of novel histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

A non-isotopic assay for histone deacetylase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

[Synthesis of pyridylalanines]

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800196

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800196

1 reference

15 September 2017

1 reference